top of page

ENACT-REACT COVID (MS)

Start Date:
March 2020
End Date:
March 2022
Duration:
24 months
ID-CARE Role:
Website:
Leader
Description
Title: Study of gut microbiome signatures in COVID-19.
Design: Longitudinal laboratory-based prospective study.
Primary Objective: to assess changes in the gut microbiome composition over time according to disease severity and treatment.
Secondary Objective: to find markers of microbiome composition correlated to immunological markers of infections; to assess changes in microbiome according to coinfections.
Partners
University of Verona
Sponsor

From our Blog
In the News
bottom of page